Table 1 Relationship between Osteopontin expression and clinicopathological findings
From: Expression of Osteopontin in oesophageal squamous cell carcinoma
Osteopontin | ||||
|---|---|---|---|---|
Positive | Negative | |||
Total ( n =175) | n =84 (48.0%) | n =91 (52.0%) | P -value | |
Age | ||||
Mean | 62.8 | 63.3 | 0.7041 | |
SDa | 8.0 | 9.8 | ||
Gender | ||||
Male | 160 | 80 (87.9) | 80 (95.2) | 0.0775 |
Female | 15 | 11 (12.1) | 4 (4.8) | |
Tumour location | ||||
Upper | 23 | 15 (16.5) | 8 (9.5) | 0.1611 |
Middle | 92 | 50 (55.0) | 42 (50.0) | |
Lower | 60 | 26 (28.5) | 34 (40.5) | |
Histology | ||||
Well | 62 | 29 (34.5) | 33 (36.3) | 0.5678 |
Moderate | 85 | 39 (46.6) | 46 (50.5) | |
Poor | 28 | 16 (19.1) | 12 (13.8) | |
pT | ||||
pT1 | 58 | 24 (28.6) | 34 (37.4) | 0.4339 |
pT2 | 22 | 9 (10.7) | 13 (14.3) | |
pT3 | 66 | 35 (41.7) | 31 (34.0) | |
pT4 | 29 | 16 (19.0) | 13 (14.3) | |
pN | ||||
pN0 | 78 | 27 (32.1) | 51 (56.0) | 0.0015 |
pN1 | 97 | 57 (77.9) | 40 (44.0) | |
pM | ||||
pM0 | 131 | 57 (67.9) | 74 (81.3) | 0.1398 |
pM1 | 44 | 27 (32.1) | 17 (18.7) | |
Stage | ||||
I | 41 | 14 (16.7) | 27 (29.7) | 0.0333 |
IIA | 31 | 12 (14.2) | 19 (20.9) | |
IIB | 21 | 14 (16.7) | 7 (7.7) | |
III | 38 | 17 (20.2) | 21 (23.1) | |
IV | 44 | 27 (32.2) | 17 (18.6) | |
Lymphatic invasion | ||||
Negative | 66 | 25 (29.8) | 41 (45.1) | 0.0375 |
Positive | 109 | 59 (70.2) | 50 (54.9) | |
Venous invasion | ||||
Negative | 125 | 52 (61.9) | 66 (72.5) | 0.1339 |
Positive | 50 | 32 (38.1) | 25 (27.5) | |
